Rural Residents Continue to Have Higher Odds of Skin Cancer
By Lori Solomon HealthDay Reporter
TUESDAY, July 9, 2024 -- Urban-rural disparities in skin cancer prevalence continue to persist, according to a study published in the June issue of the Journal of Drugs in Dermatology.
Rachel R. Lin, from the University of Miami Miller School of Medicine, and colleagues used data from the Behavior Risk Factor Surveillance Survey (2018 to 2021) to compare the prevalence of skin cancer by urban versus rural status.
The researchers found that rural residents were significantly more likely to have a positive skin cancer history across most social determinants of health, including across all races. Compared with urban peers, rural non-Hispanic White individuals had greater odds of skin cancer history (odds ratio, 1.40). The odds of skin cancer history were nearly doubled for rural Black (odds ratio, 1.74), Hispanic (odds ratio, 2.31), and other-race, non-Hispanic individuals (odds ratio, 1.99), while the odds were 20-fold higher for Asians (odds ratio, 20.46). When household income was more than $100,000, there were no significant differences noted in prevalence or odds of skin cancer history between urban and rural settings.
"Increasing awareness of vulnerable sociodemographic groups can help direct necessary attention to these communities regarding skin cancer prevention and screening," the authors write. "More research is needed to further disseminate risk and determine effective public health strategies for skin cancer among these rural communities."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2024
Read this next
Mismatch Repair Germline Pathogenic Variants Could Predispose to Uveal Melanoma
FRIDAY, June 20, 2025 -- Mismatch repair (MMR) germline alterations are enriched among patients with uveal melanoma (UM), according to a study published online June 18 in JAMA...
AI Model Can Aid Physicians in Skin Cancer Diagnoses
TUESDAY, June 17, 2025 -- The PanDerm artificial intelligence (AI) model improves skin cancer diagnosis when used by doctors, according to a research article published online June...
Mitochondrial Genetics Key to Metastatic Melanoma Immunotherapy Resistance
THURSDAY, June 12, 2025 -- For patients with metastatic melanoma, mitochondrial (MT) haplogroup T (HG-T) is associated with resistance to an anti-programmed cell death...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.